J&J’s cardiovascular business boosts medtech growth in 2025

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. By the numbers   2025 medtech sales: $33.79 billion 6.1% growth year over year   Cardiovascular sales: $8.93 billion 15.8% growth year over year   Orthopedic sales: $9.26 billion 1.1% growth year over year Johnson & Johnson’s cardiovascular segment fueled strong sales growth for the healthcare giant’s medical device business in 2025. The cardiovascular bus ...